What is Pyrimethamine 25 mg used for?

In the pharmaceutical industry, Pyrimethamine 25 mg is a potent folic acid antagonist and an essential antiparasitic agent. As a pharmacist and manufacturer, I classify this as a “specialty anti-infective,” primarily used for serious protozoal infections rather than standard bacterial ones.

Primary Clinical Uses

  • Toxoplasmosis: This is the primary indication. It is used in combination with a sulfonamide (like Sulfadiazine) to treat Toxoplasma gondii infections, which can be life-threatening in immunocompromised patients (e.g., those with HIV/AIDS) or during pregnancy (congenital toxoplasmosis).

  • Malaria Treatment: It is often used as a component of SP (Sulfadoxine-Pyrimethamine) for the treatment of uncomplicated malaria.

  • Malaria Prophylaxis: In specific high-risk regions, it is used for the prevention of malaria, particularly in pregnant women as part of Intermittent Preventive Treatment (IPTp).

  • Cystoisosporiasis: Occasionally used off-label to treat infections caused by the parasite Cystoisospora belli.

Mechanism of Action: Inhibition of Dihydrofolate Reductase

Pyrimethamine works by disrupting the parasite’s ability to synthesize DNA.

Enzyme Blockade: It selectively inhibits the enzyme dihydrofolate reductase (DHFR) in the parasite.

Folic Acid Depletion: By blocking this enzyme, the parasite cannot convert dihydrofolate into tetrahydrofolate (the active form of folic acid).

DNA Synthesis Failure: Without active folate, the parasite cannot produce the purines and pyrimidines required for DNA replication, leading to its death.

Selectivity: The drug has a much higher affinity for the protozoal DHFR enzyme than the human version, though it can still affect human folate levels over time.

The Manufacturer’s Perspective: Technical & Safety

From a production and B2B standpoint at your WHO-GMP facility in Mumbai, Pyrimethamine 25 mg involves critical technical considerations:

  • The “Leucovorin” Requirement: As a pharmacist, you know that long-term Pyrimethamine therapy can cause bone marrow suppression. For your B2B clients, a major “professional touch” is recommending the co-administration of Leucovorin (Folinic Acid) to protect the patient’s blood cells without interfering with the drug’s effect on the parasite.

  • Fixed-Dose Combinations (FDCs): While the 25 mg standalone tablet is essential, the most popular export format for malaria is the FDC with Sulfadoxine (Sulfadoxine 500 mg + Pyrimethamine 25 mg). Listing both on your marketplace is a smart move.

  • Stability & API Sourcing: The API is relatively stable but must be protected from light. At our facility, we utilize opaque PVC/PVDC or Alu-Alu blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • Dossier Support: Because this is an “Essential Medicine” for HIV/AIDS and Malaria programs, we provide full CTD/eCTD Dossiers to support international NGO tenders and ministry of health registrations.

What is Pyrazinamide 400mg used for?.

In the pharmaceutical industry, Pyrazinamide 400 mg is a core First-Line Antitubercular agent. As a pharmacist and manufacturer, I classify this as a “sterilizing” drug. It is one of the four essential components of the RIPE (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol) regimen used to treat tuberculosis.Its primary clinical value lies in its unique ability to kill dormant or “persister” bacilli that other antibiotics cannot reach.

Primary Clinical Uses

  • Active Tuberculosis (Pulmonary and Extra-pulmonary): It is used strictly during the Initial Phase (intensive phase) of TB treatment, typically for the first 2 months of a 6-month course.

  • Shortening Treatment Duration: Before Pyrazinamide was standard, TB treatment lasted 9 to 12 months. Its inclusion allowed the medical community to shorten the standard regimen to 6 months by rapidly killing off the slow-growing bacteria.

  • Multi-Drug Resistant TB (MDR-TB): It is often retained in second-line regimens if the strain remains susceptible.

Mechanism of Action: The “Intracellular Sniper”

Pyrazinamide is a prodrug that only becomes active under specific, stressful conditions created by the human body’s immune response.

Conversion: The drug enters the Mycobacterium tuberculosis bacterium, where the enzyme pyrazinamidase converts it into its active form, Pyrazinoic Acid.

Acidic Environment Targeting: It works best in an acidic environment (pH < 5.5). In the body, this occurs inside macrophages (immune cells) where the TB bacteria hide.

Disruption of Membrane Potential: Pyrazinoic acid leaks out of the bacilli and is then pulled back in, disrupting the bacterial membrane potential and interfering with energy (ATP) production.

Sterilization: By collapsing the energy source of the bacteria, it kills the “semi-dormant” population that usually survives the initial attack by Isoniazid.

The Manufacturer’s Perspective: Technical & Export

From a production and global trade standpoint at your WHO-GMP facility in Mumbai, Pyrazinamide 400 mg is a high-volume essential:

  • The 400 mg vs. 500 mg Debate: While 500 mg is common, the 400 mg tablet is frequently requested for Fixed-Dose Combinations (FDCs) and pediatric-adjusted weight-based dosing. Offering both shows your firm’s flexibility in international tenders.

  • Uric Acid Monitoring: As a pharmacist, you know Pyrazinamide inhibits the excretion of uric acid. Your Product Information Leaflet (PIL) must include a caution regarding Hyperuricemia (which can trigger Gout). Providing this technical data on your digital platform builds professional recognition.

  • Stability & Bulk Production: Pyrazinamide is a relatively stable API but requires high-quality binders to ensure proper tablet hardness and dissolution. At our Mumbai facility, we prioritize Alu-Alu or high-barrier PVC/PVDC blisters for export to the African and SE Asian markets.

  • Dossier & Global Health: This is a “Prequalified” category drug for many international NGOs. We provide full CTD/eCTD Dossiers to support your firm in bidding for national TB control programs.

 

What is Propranolol 40 mg used for?

In the pharmaceutical industry, Propranolol Hydrochloride 40 mg is a landmark non-selective beta-blocker. As a pharmacist and manufacturer, I classify this as a “multi-system” medication. Unlike cardio-selective blockers that only target the heart, Propranolol’s non-selective nature allows it to cross the blood-brain barrier, making it effective for both physical and neurological conditions.

Primary Clinical Uses

  • Hypertension (High Blood Pressure): Used to lower blood pressure, reducing the risk of strokes and heart attacks.

  • Angina Pectoris: For the long-term management of chest pain by reducing the oxygen demand of the heart muscle.

  • Arrhythmias: Used to control heart rhythm, particularly in cases of supraventricular tachycardia.

  • Migraine Prophylaxis: One of the most common uses for the 40 mg dose; it is taken daily to reduce the frequency and severity of migraine attacks.

  • Essential Tremor: It is the “gold standard” treatment for reducing involuntary shaking of the hands and head.

  • Anxiety (Performance/Social): Frequently prescribed off-label to manage the physical symptoms of anxiety, such as palpitations, sweating, and tremors (common for public speaking).

  • Hyperthyroidism: Used to manage symptoms like rapid heart rate and tremors in patients with overactive thyroids.

Mechanism of Action: Competitive Antagonism

Propranolol works by blocking the action of epinephrine (adrenaline) and norepinephrine at specific receptor sites.

Beta-1 Blockade (Heart): It binds to $\beta_1$ receptors in the heart, decreasing the heart rate ($HR$) and the force of contraction. This reduces the cardiac output and blood pressure.

Beta-2 Blockade (Vessels/Bronchi): As a non-selective agent, it also binds to $\beta_2$ receptors. This is why it must be used with caution in asthmatic patients, as it can cause bronchoconstriction.

Lipophilicity: Because Propranolol is highly lipophilic (fat-soluble), it easily crosses the blood-brain barrier. This is why it is effective for neurological issues like migraines and tremors, whereas cardio-selective blockers like Atenolol are not.

The Manufacturer’s Perspective: Formulation & Export

From a production and B2B standpoint at your WHO-GMP facility in Mumbai, the 40 mg strength is a high-volume essential:

  • The 40 mg “Sweet Spot”: While 10 mg is used for mild anxiety, the 40 mg tablet is the standard therapeutic dose for hypertension and migraine prevention. Offering this strength with a central break-line (score) is a major USP, as it allows for 20 mg titration.

  • Bioavailability & First-Pass Metabolism: Propranolol undergoes significant hepatic first-pass metabolism. At our facility, we ensure strict In-Vitro Dissolution Testing to ensure that your generic version is bioequivalent to the innovator (Inderal).

  • Packaging for Stability: Propranolol is light-sensitive. We utilize Amber-colored PVC/PVDC or Alu-Alu blister packaging to ensure a 36-month shelf life, especially for export to Zone IVb regions where light and humidity are intense.

  • Dossier & Compliance: This molecule is on the WHO Model List of Essential Medicines. We provide full CTD/eCTD Dossiers to support your international trade and pharmacy registrations.

 

 

What is Promethazine Hydrochloride 25mg used for?

In the pharmaceutical industry, Promethazine Hydrochloride 25 mg is a versatile, first-generation phenothiazine derivative. As a pharmacist and manufacturer, I classify this as a “multi-functional antihistamine” because it possesses antihistaminic, sedative, antiemetic, and anticholinergic properties all in one molecule.

Primary Clinical Uses

  • Allergic Reactions: Treatment of hay fever (allergic rhinitis), allergic conjunctivitis, and skin conditions like urticaria (hives) or angioedema.

  • Motion Sickness: Highly effective for the prevention and treatment of nausea and vomiting associated with travel.

  • Nausea and Vomiting: Used post-operatively or in cases of severe gastroenteritis to control emesis.

  • Sedation: Frequently used as a pre-operative sedative to relieve apprehension and induce light sleep, or for short-term management of insomnia.

  • Adjunctive Analgesia: It is often combined with opioids (like Codeine) because it enhances the pain-relieving effect while counteracting the nausea often caused by those drugs.

Mechanism of Action: Multi-Receptor Antagonism

Promethazine is a “dirty drug” in pharmacological terms, meaning it acts on several different receptors, which accounts for its wide range of uses.

H1-Receptor Antagonism: It competes with free histamine for $H_1$-receptor sites. By blocking these, it stops the swelling, itching, and redness of an allergic response.

Blood-Brain Barrier: Because it is highly lipophilic, it crosses the blood-brain barrier easily, leading to significant sedation and its anti-motion sickness effect.

Anticholinergic Action: It blocks muscarinic receptors, which helps “dry up” secretions in the respiratory tract and reduces the signals from the inner ear to the brain that cause motion sickness.

Dopaminergic Blockade: In the Chemoreceptor Trigger Zone (CTZ), it weakly blocks dopamine receptors, contributing to its anti-nausea profile.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint at your WHO-GMP facility in Mumbai, Promethazine 25 mg involves several technical considerations:

  • Photosensitivity: Promethazine is notoriously light-sensitive and can undergo oxidative degradation. At our facility, we utilize Amber-colored PVC/PVDC or Alu-Alu blister packaging to ensure a 36-month shelf life.

  • The “Phenergan” Standard: In most B2B export markets (especially the UK, Africa, and SE Asia), the 25 mg tablet is the benchmark. Marketing your product as “Phenergan-equivalent” in your digital catalog is a major strategy for international trade.

  • Pediatric Warning (Technical Compliance): As a pharmacist, you must ensure your Product Information Leaflet (PIL) includes the strict warning against use in children under 2 years of age due to the risk of potentially fatal respiratory depression—a critical regulatory requirement for export.

  • Dossier Support: This is an essential medicine for hospital supply chains. We provide full CTD/eCTD Dossiers to help you participate in international tenders and pharmacy registrations.

What is Primaquine phosphate 7.5 mg used for?

In the pharmaceutical industry, Primaquine Phosphate 7.5 mg is a critical 8-aminoquinoline antimalarial. As a pharmacist and manufacturer, I classify this as the “radical cure” agent. While other drugs kill the parasites in the blood, Primaquine is unique because it targets the parasites “hiding” in the liver.

Primary Clinical Uses

  • Radical Cure of P. vivax and P. ovale: This is its primary indication. It is used to eliminate the hypnozoites (dormant stages) of malaria in the liver, preventing the patient from suffering a relapse months or years later.

  • Gameticidal Action (P. falciparum): It is used as a single dose to kill the gametocytes (the sexual stage) of the parasite in the blood. This prevents the transmission of malaria from an infected human back to a mosquito, acting as a public health tool to stop the spread.

  • Pneumocystis Jirovecii Pneumonia (PCP): Occasionally used as an alternative second-line treatment (combined with Clindamycin) for PCP in immunocompromised patients.

Mechanism of Action: Oxidative Stress

Primaquine works by disrupting the metabolic processes of the parasite within the liver cells.

Mitochondrial Interference: It interferes with the parasite’s electron transport chain and mitochondrial function.

Oxidative Damage: The drug is metabolized into highly reactive intermediates that induce oxidative stress.

DNA Disruption: These reactive oxygen species damage the parasite’s DNA and protein synthesis, effectively “flushing out” the dormant liver stages that other antimalarials cannot reach.

The Manufacturer’s Perspective: Technical & Safety

From a production and global trade standpoint at your WHO-GMP facility in Mumbai, Primaquine 7.5 mg requires strict technical oversight:

  • The G6PD Constraint (Critical Safety): As a pharmacist, you know that Primaquine can cause acute hemolytic anemia in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. For your B2B export clients, ensuring that your Product Information Leaflet (PIL) emphasizes G6PD testing before administration is a mark of a high-quality, responsible manufacturer.

  • Dosing Variations: We manufacture the 7.5 mg and 15 mg strengths. The 7.5 mg tablet is particularly useful for precise weight-based dosing in pediatric cases or for the 14-day radical cure regimen.

  • Stability & Packaging: Primaquine is sensitive to light and moisture. At our Mumbai facility, we utilize Alu-Alu or Amber-colored PVC/PVDC blisters to ensure a 36-month shelf life, which is vital for government tenders and export to Zone IVb regions.

  • Dossier Support: This is a cornerstone of the WHO Global Malaria Program. We provide full CTD/eCTD Dossiers to support international registration and supply.

What is Prednisolone 5mg used for?

In the pharmaceutical industry, Prednisolone 5 mg is a synthetic Glucocorticoid and a derivative of cortisol. As a pharmacist and manufacturer, I view the 5 mg strength as the “titration gold standard.” It is the most versatile dose for long-term maintenance therapy, allowing clinicians to taper patients down to the lowest effective dose to minimize side effects.

Primary Clinical Uses

Prednisolone is a systemic anti-inflammatory and immunosuppressant used across almost every medical specialty:

  • Allergic Conditions: Management of severe asthma, drug hypersensitivity reactions, and serum sickness.

  • Dermatological Diseases: Treatment of severe Psoriasis, Pemphigus, and exfoliative dermatitis.

  • Rheumatic Disorders: Used as adjunctive therapy for short-term administration in Rheumatoid Arthritis, Gouty Arthritis, and Ankylosing Spondylitis.

  • Autoimmune Disorders: Management of Systemic Lupus Erythematosus (SLE) and acute exacerbations of Multiple Sclerosis.

  • Endocrine Disorders: Primary or secondary adrenocortical insufficiency (Addison’s disease).

  • Ophthalmology: Control of severe acute and chronic allergic and inflammatory processes involving the eye.

Mechanism of Action: Genomic Modulation

Prednisolone works by entering the cell nucleus and altering gene expression.

Cytoplasmic Binding: Prednisolone diffuses across cell membranes and binds to specific Glucocorticoid Receptors (GR).

Translocation: The drug-receptor complex moves into the cell nucleus.

Inhibition of Inflammatory Mediators: It inhibits the transcription of genes that code for pro-inflammatory cytokines (like IL-1, IL-6, and TNF-alpha).

Annexin-1 Production: It stimulates the synthesis of lipocortin-1 (Annexin-1), which inhibits phospholipase A2—the enzyme responsible for releasing arachidonic acid (the precursor to prostaglandins and leukotrienes).

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint at your WHO-GMP facility in Mumbai, Prednisolone 5 mg involves specific technical considerations:

  • The “Tapering” USP: On your digital platforms, you should highlight that your 5 mg tablets are cross-scored (quadrisected). This is a major selling point for B2B clients because it allows patients to accurately take 1.25 mg or 2.5 mg doses during the critical “tapering off” phase to avoid adrenal crisis.

  • Stability and Photosensitivity: Prednisolone is sensitive to light. At our facility, we utilize Alu-Alu or Amber-colored PVC/PVDC blisters to ensure a 36-month shelf life, especially for export to Zone IVb regions where high UV index and humidity are factors.

  • Bioavailability: As a BCS Class I drug (high solubility, high permeability), the 5 mg tablet must meet strict dissolution profiles. Our Mumbai facility ensures that >80% of the API is released within 30 minutes to ensure rapid clinical onset.

  • Dossier Support: This is a core “Essential Medicine.” We provide full CTD/eCTD Dossiers to support international registration and participation in government and NGO tenders.

What is Prazosin 2.5 mg used for?

In the pharmaceutical industry, Prazosin 2.5 mg is a selective Alpha-1 ($\alpha_1$) Adrenergic Antagonist. As a pharmacist and manufacturer, I view Prazosin as a highly versatile molecule that has transitioned from being a primary antihypertensive to a specialized treatment for both urological and psychological conditions.

Primary Clinical Uses

  • Hypertension (High Blood Pressure): Used as an adjunctive therapy to lower blood pressure, often when other medications are insufficient.

  • Benign Prostatic Hyperplasia (BPH): It helps improve urine flow in men with enlarged prostates by relaxing the smooth muscles of the bladder neck and prostate.

  • PTSD-Related Nightmares (Off-label): A unique and common use in modern psychiatry to reduce the frequency and intensity of nightmares and sleep disturbances associated with Post-Traumatic Stress Disorder.

  • Raynaud’s Phenomenon: Used to improve circulation and reduce vasospasms in the fingers and toes.

  • Congestive Heart Failure: Occasionally used to reduce the workload on the heart by decreasing systemic vascular resistance.

Mechanism of Action: Selective Vasodilation

Prazosin works by blocking the signals that cause blood vessels and certain smooth muscles to tighten.

Competitive Inhibition: It selectively binds to and blocks $\alpha_1$-adrenergic receptors on the smooth muscle cells of the blood vessel walls and the prostate.

Relaxation: By blocking the action of norepinephrine (which normally causes these muscles to contract), Prazosin causes the vessels to dilate (widen).

Result: This leads to a decrease in peripheral vascular resistance, lowering blood pressure and easing the passage of urine without significantly affecting heart rate (unlike non-selective alpha-blockers).

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint at your WHO-GMP facility in Mumbai, Prazosin 2.5 mg requires specific technical attention:

  • The “First-Dose” Phenomenon: Prazosin can cause a sudden, severe drop in blood pressure (syncope) upon the first dose. As a firm owner, ensuring your Product Information Leaflet (PIL) includes a “start low, go slow” warning and advice to take the first dose at bedtime is a critical regulatory and safety requirement.

  • The 2.5 mg “Mid-Range” Strength: While 1 mg is the starting dose, the 2.5 mg tablet is a high-volume product for your B2B marketplace because it is the standard maintenance dose for most chronic conditions.

  • Stability & Packaging: Prazosin is sensitive to light and moisture. At our Mumbai facility, we utilize Alu-Alu blister packaging or Amber-colored PVC/PVDC to ensure a 36-month shelf life, especially for export to Zone IVb regions.

  • B2B & Dossier Support: We provide full CTD/eCTD Dossiers to support international registration against the innovator (Minipress).

What is Praziquantel 600 mg used for?

In the pharmaceutical industry, Praziquantel 600 mg is the “gold standard” anthelminthic (anti-parasitic) medication specifically designed to target trematodes (flukes) and cestodes (tapeworms).

As a pharmacist and manufacturer, I view Praziquantel as one of the most essential medicines in global health. It is the primary weapon used in mass drug administration (MDA) programs to combat tropical parasitic diseases.

Primary Clinical Uses

  • Schistosomiasis (Bilharzia): This is the primary use case. It treats infections caused by all species of Schistosoma (blood flukes).

  • Liver Flukes: Effective against Clonorchis sinensis (Chinese liver fluke) and Opisthorchis viverrini.

  • Lung Flukes: Used to treat Paragonimus westermani.

  • Tapeworm Infections (Cestodes): Used for intestinal tapeworms (like Taenia saginata or Taenia solium) and is the drug of choice for Neurocysticercosis (parasitic cysts in the brain).

Mechanism of Action: The Calcium Influx

Praziquantel works by causing a rapid and lethal change in the parasite’s cell membrane.

Membrane Permeability: It increases the permeability of the parasite’s cell membranes to calcium ions ($Ca^{2+}$).

Tetanic Contraction: This sudden influx of calcium causes massive, immediate contraction (paralysis) of the worm’s muscles.

Integumentary Damage: The drug causes the parasite’s outer “skin” (integument) to vacuolize and disintegrate.

Phagocytosis: Once the protective skin is damaged, the parasite is easily attacked and digested by the host’s own immune system (white blood cells).

The Manufacturer’s Perspective: Formulation & Export

From a production standpoint at your WHO-GMP facility in Mumbai, Praziquantel 600 mg presents unique technical challenges and opportunities:

  • The “Bitter API” Challenge: Praziquantel has an extremely bitter, metallic taste that can cause gagging. As a manufacturer, we utilize high-quality film-coating or sugar-coating to ensure the 600 mg tablet is palatable. Highlighting “Taste-Masked Technology” on your digital platform is a major B2B selling point.

  • Scoring for Dosing: Praziquantel dosing is usually weight-based ($40\text{–}60\text{ mg/kg}$). Therefore, the 600 mg tablet must be manufactured with triple-scoring (three deep break lines) to allow the tablet to be split into 150 mg segments for accurate pediatric dosing.

  • BCS Class II (Solubility): It has low water solubility. Our QC lab ensures that the dissolution profile meets USP standards to ensure maximum bioavailability once ingested.

  • Global Tenders: Because this is on the WHO Model List of Essential Medicines, it is a high-volume item for UN and NGO tenders (like UNICEF or USAID). Our Mumbai facility provides the full eCTD Dossiers needed for these massive international contracts.https://healthyinc.co.in/product/praziquantel-tablets

What is Pioglitazone 15 mg used for?

In the pharmaceutical industry, Pioglitazone 15 mg is a potent Thiazolidinedione (TZD), often referred to as an “insulin sensitizer.” As a pharmacist and manufacturer, I view the 15 mg strength as the critical starting dose for managing insulin resistance, which is the root cause of Type 2 Diabetes.

Primary Clinical Uses

  • Type 2 Diabetes Mellitus: It is indicated as an adjunct to diet and exercise to improve glycemic control. It is particularly effective for patients who have “metabolic syndrome” or significant insulin resistance.

  • Monotherapy or Combination: It can be used alone or in combination with Metformin, Sulfonylureas, or Insulin when those agents alone do not provide adequate glucose control.

  • NASH (Off-label): In specialized hepatology, low-dose Pioglitazone is sometimes used to treat Non-Alcoholic Steatohepatitis because of its ability to reduce fat accumulation in the liver.

Mechanism of Action: The PPAR-$\gamma$ Activator

Pioglitazone works at the genetic level to change how the body handles glucose.

Receptor Binding: It is a potent and selective agonist for Peroxisome Proliferator-Activated Receptor-gamma (PPAR-$\gamma$). These receptors are found in adipose tissue, skeletal muscle, and the liver.

Gene Transcription: Activation of these receptors modulates the transcription of genes involved in glucose and lipid metabolism.

Insulin Sensitization: It increases the number of glucose transporter proteins (GLUT-4). This allows cells to “open their doors” to insulin more easily, sucking glucose out of the bloodstream and into the muscles and fat cells.

Hepatic Glucose Reduction: It also decreases the amount of glucose the liver produces overnight.

The Manufacturer’s Perspective: Technical & Export

From a production standpoint at your WHO-GMP facility in Mumbai, Pioglitazone 15 mg involves specific technical considerations:

  • The 15 mg Titration Strategy: As a firm owner, your marketing should emphasize that 15 mg is the safest “entry dose.” It allows doctors to monitor for side effects like fluid retention (edema) before moving the patient to 30 mg or 45 mg.

  • Stability & Moisture: Pioglitazone is sensitive to moisture. At our facility, we utilize Alu-Alu blister packaging to ensure a 36-month shelf life. This is a major USP for export to Zone IVb regions where high humidity can otherwise degrade the tablet.

  • Safety Warnings (The “Bladder” Note): For regulatory compliance and professional recognition, your Product Information Leaflet (PIL) must include warnings regarding active bladder cancer and heart failure (NYHA Class III/IV), as these are standard global contraindications.

  • B2B & Dossier Support: This is a high-value product for chronic disease management. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Actos).

What is Phenytoin 100mg used for?

In the pharmaceutical industry, Phenytoin 100 mg is a first-line Hydantoin-class Anticonvulsant. As a pharmacist and manufacturer, I classify this as a “voltage-gated channel blocker.” It is one of the most widely used and cost-effective medications for the long-term management of epilepsy worldwide.

Primary Clinical Uses

  • Generalized Tonic-Clonic Seizures: Primary treatment for grand mal seizures.

  • Complex Partial Seizures: Management of focal seizures that affect awareness.

  • Status Epilepticus: Used as a loading dose (often in injectable form) to prevent the recurrence of seizures after they have been acutely stopped by benzodiazepines.

  • Post-Neurosurgery Prophylaxis: Given to patients following brain surgery or head trauma to prevent “provoked” seizures.

  • Trigeminal Neuralgia (Off-label): Occasionally used for nerve pain when first-line agents like Carbamazepine are not tolerated.

Mechanism of Action: Frequency-Dependent Blockade

Phenytoin works by selectively stabilizing hyper-excited neuronal membranes without significantly depressing normal brain activity.

Sodium Channel Binding: It binds to voltage-gated sodium channels while they are in their inactive state.

Prolonging Inactivation: By keeping these channels closed for longer periods, it prevents the high-frequency repetitive firing of action potentials.

Selective Inhibition: This is “use-dependent,” meaning it primarily targets neurons that are firing abnormally fast (the seizure focus) while leaving normal-speed neurons mostly unaffected.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint at your WHO-GMP facility in Mumbai, Phenytoin 100 mg is a technically demanding product:

  • The Bioavailability Challenge: Phenytoin has a narrow therapeutic index and follows nonlinear (Michaelis-Menten) kinetics. Small changes in formulation can lead to massive changes in blood levels. As a firm owner, your Dissolution Profile must be perfectly consistent to avoid toxicity or treatment failure.

  • Phenytoin Sodium vs. Phenytoin Base: In the export market, we typically manufacture Phenytoin Sodium. You must clearly state this on your digital platform, as 100 mg of Phenytoin Sodium is only equivalent to approximately 92 mg of Phenytoin Base.

  • Teratogenic Warning: As a pharmacist, you must ensure the Product Information Leaflet (PIL) includes the “Fetal Hydantoin Syndrome” warning, as it is a Category D drug in pregnancy.

  • Stability & Packaging: Phenytoin is moisture-sensitive. We utilize Alu-Alu blister packaging or HDPE bottles with induction seals to ensure a 36-month shelf life for export to Zone IVb regions.

Add to cart